Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer
Clinical trial NCT00719264 · COMPLETED
Trial details
- NCT number
- NCT00719264
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-12
- Primary completion
- 2011-12-31
- Enrollment
- 365
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.